Perikabiven Injection, Emulsion
Product Images NDC 63323-714

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Perikabiven (NDC 63323-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Per0e 0000 01

An instructional diagram of the Perikabiven intravenous injection emulsion bag showing labeled features including overpouch notch, handle, hanging hole, vertical seals, bends in vertical seals, horizontal seal, blind port (not for use), white additive port, blue infusion port, and an oxygen absorber between the bag and pouch. A reference to an online instructional video is also included.*

FDA Label Image

Per0e 0000 02

An instructional diagram illustrating the preparation steps for Perikabiven intravenous injection emulsion in a 3-chamber bag. The first step shows how to inspect the bag, noting one white chamber and two clear chambers, with instructions to discard if the overpouch is opened or damaged or if any chamber is white or solution yellow. The second step illustrates removing the overpouch by tearing from the notch and removing the oxygen absorber, highlighting correct handling before activation.*

FDA Label Image

Per0e 0000 03

Instructional illustrations showing activation steps for a Perikabiven intravenous emulsion bag. Steps include placing the bag on a flat surface with text up, rolling from top down toward ports, applying pressure to break vertical seals, mixing the contents by inverting the bag, inspecting activation by confirming the white contents, and identifying the correct ports marked white for the additive port and blue for the infusion port.*

FDA Label Image

Per0e 0000 04

An instructional illustration showing the procedure for making additive injections to a bag. Step 6a depicts breaking off the white additive port cap, holding the base horizontally, and inserting a needle through the septum. Step 6c shows injecting additives into the port. Text emphasizes aseptic technique, compatibility of additives, and needle size recommendations.*

FDA Label Image

Per0e 0000 05

An instructional diagram showing steps to spike and hang a Perikabiven intravenous infusion bag. It includes labeled illustrations and text outlining how to break off the infusion port cap, insert the spike, use a non-vented set or close the air-inlet, close the roller clamp, handle the base of the infusion port, and hang the bag by the hole below the handle. Additional notes emphasize sterility and single-use instructions.*

FDA Label Image

Per0e 0000 06

Chemical structure diagram showing a carbohydrate molecule with hydroxyl groups and oxygen atoms, including a water molecule (H2O). This likely represents the structural formula of Dextrose, one of the active ingredients in Perikabiven injection emulsion by Fresenius Kabi USA, LLC.*

FDA Label Image

Per0e 0000 07

Chemical structure diagram of an amino acid molecule showing a carboxyl group, an amino group, and a side chain with a methyl group. The image illustrates the molecular components typical for an amino acid, consistent with the product's amino acid ingredients.*

FDA Label Image

Per0e 0000 08

Chemical structure of Tryptophan, an amino acid ingredient listed in Perikabiven injection emulsion by Fresenius Kabi USA, LLC.*

FDA Label Image

Per0e 0000 09

Chemical structure of histidine, an amino acid component listed among the active ingredients in Perikabiven intravenous injection, emulsion by Fresenius Kabi USA, LLC.*

FDA Label Image

Per0e 0000 10

Chemical structure diagram of L-lysine, showing its molecular formula with an amino group, carboxyl group, and side chain characteristic of this amino acid.*

FDA Label Image

Per0e 0000 11

Chemical structure of an amino acid, showing an alpha carbon bonded to an amino group, a carboxyl group, a hydrogen atom, and a side chain represented by 'R'. This structure represents the general formula of amino acids.*

FDA Label Image

Per0e 0000 12

Chemical structure of Dextrose, shown as a molecular formula with carbon, hydrogen, and oxygen atoms.*

FDA Label Image

Per0e 0000 13

Chemical structure diagram showing three variations of a triglyceride molecule with R1, R2, and R3 representing fatty acid side chains. The image depicts the general molecular structure of triglycerides with ester bonds connecting fatty acid chains to a glycerol backbone.*

FDA Label Image

Per0e 0000 14

Chemical structure diagram showing a molecular formula with carbon, hydrogen, and oxygen atoms arranged in a linear and branched chain.*

FDA Label Image

Per0e 0000 15

Chemical structure diagram of the active ingredient in Perikabiven, showing the molecular arrangement of fatty acids characteristic of a lipid emulsion component, including hydrocarbon chains with double bonds and carboxyl groups.*

FDA Label Image

Per0e 0000 16

Chemical structure of the active ingredient depicted in the image, showing a molecular formula with carbon (C), hydrogen (H), and oxygen (O) atoms arranged in a chain and functional groups, consistent with the structure of one of the components in Perikabiven intravenous emulsion.*

FDA Label Image

Per0e 0000 17

Chemical structure diagram depicting the molecular arrangement of a compound, showing carbon (C), hydrogen (H), and oxygen (O) atoms connected by single and double bonds, consistent with an organic molecule typical of pharmaceutical ingredients.*

FDA Label Image

Per0e 0000 18

Chemical structure diagram showing a molecular formula with carbon (C), hydrogen (H), and oxygen (O) atoms, representing the structural formula of an active ingredient or component.*

FDA Label Image

Per0e 0000 19

Chemical structure diagram showing the molecular arrangement of a compound with a ring structure, hydroxyl group, and carboxyl group, consistent with an amino acid or similar molecule. The structure includes elements such as oxygen and carbon atoms connected via various single and double bonds.*

FDA Label Image

Per0e 0000 20

Chemical structure diagram showing two carboxyl groups (COOH) with R1 and R2 side chains, representing a generic molecule structure commonly used to depict amino acid or related chemical structures.*

FDA Label Image

Per0e 0000 21

Chemical structures of phosphatidylcholine and phosphatidylethanolamine, two phospholipids, illustrated in black and white chemical diagrams showing their molecular compositions and configurations.*

FDA Label Image

Per0e 0000 22

Chemical structure diagram of a carbohydrate molecule showing a chain of carbon atoms with hydroxyl (OH) groups and one aldehyde group at the end, consistent with a sugar structure.*

FDA Label Image

Per0e 0000 23

FDA Label Image

Per0e 0000 24

The image shows a 1440 mL label for Perikabiven, an amino acids, electrolytes, dextrose, and lipid injectable emulsion for intravenous use by Fresenius Kabi USA, LLC. The label includes dosing and preparation instructions, a nutritional breakdown listing calories, amino acids, dextrose, lipids, and electrolytes, as well as port identifications for additive and infusion. It features warnings, storage recommendations, and a barcode with NDC 63323-714-14.*

FDA Label Image

Per0e 0000 25

Perikabiven 4 x 1440 mL injection emulsion label for intravenous use. It contains amino acids, electrolytes, dextrose, and lipid injectable emulsion without added sulfites. The label includes storage instructions (5°C to 25°C), single dose container notice, and ordering customer service contact. Manufactured by Fresenius Kabi USA, LLC with barcode and batch details visible.*

FDA Label Image

Per0e 0000 26

The image shows the label of Perikabiven 1920 mL, an intravenous injection emulsion containing amino acids, electrolytes, dextrose, and lipids for peripheral infusion. Manufactured by Fresenius Kabi USA, the label includes activation instructions, ingredient information, nutrition content, storage, and usage warnings with clear port markings for additive and infusion use.*

FDA Label Image

Per0e 0000 27

Label for Perikabiven 4 x 1920 mL injection emulsion containing amino acids, electrolytes, dextrose, and lipid for intravenous use. The label specifies concentrations (2.4%, 0.5%, 6.8%, and 3.5%) with no sulfites added and notes it is for peripheral infusion. Storage instructions specify 5C to 25C and protection from freezing. Manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden.*

FDA Label Image

Per0e 0000 28

Perikabiven 240 mL intravenous injection emulsion label manufactured by Fresenius Kabi USA, LLC. The label identifies Perikabiven as an amino acids, electrolytes, dextrose, and lipid injectable emulsion for peripheral infusion, with preparation instructions, calorie and ingredient details, ports for additive and infusion, and storage recommendations.*

FDA Label Image

Per0e 0000 29

Perikabiven 3 x 2400 mL injection emulsion label for intravenous peripheral infusion. Contains amino acids, electrolytes, dextrose, and lipid injectable emulsion with no sulfites. Manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden. Includes storage instructions and batch information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.